November 27, 2023 Lilly’s Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds
Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials By Deena Beasley (Reuters) -In a mid-stage trial, the highest dose of Eli Lilly’s experimental pill orforglipron led to 14.7% weight loss after 36 weeks for people who were obese or overweight,…